Dadun: Browsing DSpace

Communities & Collections

	Archivo General [96]
	Depósito Académico [12509]
	Fondo Antiguo [4191]
	Materiales docentes [59]
	Publicaciones Institucionales [256]
	Revistas y series UN [14605]
	Tesis doctorales y Tesinas [161]
Browse
	Issue Date
	Author
	Title
	Subject
Sign on to:
	Statistics
	Receive email updates
	My DSpace authorized users
	Edit Profile

	Download files

	Help
	FAQs
	About DSpace

Dadun >

Browsing by Author Odero, M.D. (María D.)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:

Showing results 27 to 46 of 46

< previous

Issue Date	Title	Author(s)
2006	Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses	Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Largo, C. (Cristina); Martin, M.C. (María C.); Odero, M.D. (María D.); Prosper, F. (Felipe); Siebert, R. (Reiner); Calasanz, M.J. (Maria José); Cigudosa, J.C. (Juan Cruz)
2001	Insertion (22;9)(q11;q34q21) in a patient with chronic myeloid leukemia characterized by fluorescence in situ hybridization	Martin-Subero, J.I. (José Ignacio); Lahortiga, I. (Idoya); Gomez, E. (Emilio); Ferreira, C. (C.); Larrayoz, M.J. (María J.); Odero, M.D. (María D.); García-Delgado, M. (Marina); Novo, F.J. (Francisco Javier); Giraldo, P. (P.); Calasanz, M.J. (Maria José)
2006	Interphase FISH for the detection of breakpoints in IG loci and chromosomal changes with adverse prognostic impact in multiple myeloma with normal karyotypes	Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Odero, M.D. (María D.); Prosper, F. (Felipe); Hernandez, R. (Roberto); Cigudosa, J.C. (Juan Cruz); Siebert, R. (Reiner); Calasanz, M.J. (Maria José)
2003	Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response	Aguirre, X. (Xavier); Fontalba, A. (A.); Andreu, E.J. (E.J.); Odero, M.D. (María D.); Larrayoz, M.J. (María J.); Montiel-Duarte, C. (Cristina); Calasanz, M.J. (Maria José); Fernandez-Luna, J. (J.L.); Prosper, F. (Felipe)
1994	La «experiencia» como lugar antropológico en C. S. Lewis	*Odero, M.D. (María D.)*
2004	Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells	Lahortiga, I. (Idoya); Aguirre, X. (Xavier); Belloni, E. (E.); Vazquez, I. (Iria); Larrayoz, M.J. (María J.); Gasparini, P. (P.); Lo-Coco, F. (Francesco); Pelicci, P.G. (Pier G.); Calasanz, M.J. (Maria José); Odero, M.D. (María D.)
2003	Molecular cytogenetic characterization of breakpoints in 19 patients with hematologic malignancies and 12p unbalanced translocations	*Odero, M.D. (María D.); Carlson, K. (K.); Lahortiga, I. (Idoya); Calasanz, M.J. (Maria José); Rowley, J.D. (Janet D.)*
2004	Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements	*Lahortiga, I. (Idoya); Vazquez, I. (Iria); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Vizmanos, J.L. (José Luis); Gozzetti, A. (A.); Calasanz, M.J. (Maria José); Odero, M.D. (María D.)*
2007	Multicolor interphase cytogenetics for the study of plasma cell dyscrasias	Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Odero, M.D. (María D.); Prosper, F. (Felipe); Cigudosa, J.C. (Juan Cruz); Schoch, R. (Robert); Calasanz, M.J. (Maria José); Siebert, R. (Reiner)
2001	New cytogenetic prognostic markers in breast cancer	*Zudaire, I. (Isabel); Odero, M.D. (María D.); Caballero, M.C. (M.C.); Valenti, C. (C.); Martinez-Peñuela, J.M. (J.M.); Calasanz, M.J. (Maria José)*
2004	NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder	Vizmanos, J.L. (José Luis); Novo, F.J. (Francisco Javier); Roman, J.P. (José P.); Baxter, E.J. (E.J.); Lahortiga, I. (Idoya); Larrayoz, M.J. (María J.); Odero, M.D. (María D.); Giraldo, P. (P.); Calasanz, M.J. (Maria José); Cross, N.C.P. (Nicholas C.P.)
2003	NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15)	Lahortiga, I. (Idoya); Vizmanos, J.L. (José Luis); Aguirre, X. (Xavier); Vazquez, I. (Iria); Cigudosa, J.C. (Juan Cruz); Larrayoz, M.J. (María J.); Sala, F. (Francisco); Gorosquieta, A. (A.); Perez-Equiza, K. (Katy); Calasanz, M.J. (Maria José); Odero, M.D. (María D.)
2005	NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2	Lahortiga, I. (Idoya); Belloni, E. (E.); Vazquez, I. (Iria); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Vizmanos, J.L. (José Luis); Valgañon, M. (Mikel); Zudaire, I. (Isabel); Saez, B. (Borja); Mateos, M.C. (María C.); Di-Fiore, P.P. (Pier Paolo); Calasanz, M.J. (Maria José); Odero, M.D. (María D.)
2012	Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia	*Cristobal, I. (Ion); Garcia-Orti, L. (Laura); Cirauqui, C. (Cristina); Cortes-Lavaud, X. (Xabier); Garcia-Sanchez, M.A. (María A.); Calasanz, M.J. (María José); Odero, M.D. (María D.)*
2005	p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV	Valgañon, M. (Mikel); Giraldo, P. (P.); Aguirre, X. (Xavier); Larrayoz, M.J. (María J.); Rubio-Martinez, A. (Araceli); Rubio-Felix, D. (Daniel); Calasanz, M.J. (Maria José); Odero, M.D. (María D.)
2004	Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion	Vizmanos, J.L. (José Luis); Larrayoz, M.J. (María J.); Vazquez, I. (Iria); Odero, M.D. (María D.); Hernandez, R. (Roberto); Lahortiga, I. (Idoya); Novo, F.J. (Francisco Javier); Ardanaz, M.T. (M.T.); Calasanz, M.J. (Maria José)
2003	Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases	*Panizo, C. (Carlos); Patiño, A. (Ana); Lecumberri, R. (Ramón); Calasanz, M.J. (Maria José); Odero, M.D. (María D.); Bendandi, M. (Maurizio); Rocha, E. (Eduardo)*
2010	Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia	Vazquez, I. (Iria); Maicas, M. (Miren); Marcotegui, N. (Nerea); Conchillo, A. (Ana); Guruceaga, E. (Elizabeth); Roman-Gomez, J. (José); Calasanz, M.J. (Maria José); Aguirre, X. (Xavier); Prosper, F. (Felipe); Odero, M.D. (María D.)
2007	Simultaneous translocations of FGFR3/MMSET and CCND1 into two different IGH alleles in multiple myeloma: lack of concurrent activation of both proto-oncogenes	Saez, B. (Borja); Martin-Subero, J.I. (José Ignacio); Lahortiga, I. (Idoya); Largo, C. (Cristina); Larrayoz, M.J. (María J.); Odero, M.D. (María D.); Prosper, F. (Felipe); Cigudosa, J.C. (Juan Cruz); Siebert, R. (Reiner); Calasanz, M.J. (Maria José)
2003	t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia	Vizmanos, J.L. (José Luis); Larrayoz, M.J. (María J.); Lahortiga, I. (Idoya); Floristan, F. (Filomena); Alvarez, C. (Carmen); Odero, M.D. (María D.); Novo, F.J. (Francisco Javier); Calasanz, M.J. (Maria José)

Showing results 27 to 46 of 46

< previous